Orlando Health Names New President of Orlando Health Cancer Institute

Orlando, FL (March 29, 2024) – Rafael Mañon, MD, has been named president of the Orlando Health Cancer Institute, where he will have oversight of the organization’s oncology services.

Dr. Mañon brings nearly two decades of experience to this role, serving as a dynamic physician leader and knowledgeable and compassionate patient care provider at Orlando Health Cancer Institute since 2005.

He is currently Chairman of the Department of Radiation Oncology and has previously served in several leadership roles, including Radiation Safety Committee Chairman, Head and Neck Quality Committee Chairman and Radiation Oncology Research Director.

His professional affiliations include the American Society of Clinical Oncology, the American Society for Radiation Oncology, and NRG Oncology.

Dr. Mañon has also been published in numerous medical journals and textbooks, served as principal investigator on clinical research studies and been a frequent presenter at national conferences.

“Dr. Mañon feels his greatest responsibility is to serve the community with the highest level of quality cancer care” said Cary D’Ortona, President Orlando Health Medical Group. As a leader in cancer care, Dr. Mañon is committed to connecting with patients to bring clarity and understanding to the challenges they are facing.”

A graduate of the University of Florida College of Medicine, Dr. Mañon completed an internal medicine internship at Jackson Memorial Hospital in Miami and a radiation oncology residency at the University of Wisconsin, where he served as chief resident.

At Orlando Health Cancer Institute, patients have access to the most current, state-of-the-art cancer-fighting technologies.

• The Institute recently received FDA approval for its TIL or tumor-infiltrating lymphocytes therapy to treat aggressive, late-stage melanoma and other advanced cancers.
• It is Central Florida’s only provider of proton therapy, an advanced form of radiation therapy that uses proton beams rather than X-rays to treat selected tumors in adult and pediatric patients.
• Orlando Health Cancer Institute’s Bone Marrow Transplant and Cellular Therapy program has been recognized among the top 12 performing centers in the nation by the Center for International Blood and Marrow Transplant Research (CIBMTR).

About Orlando Health

Orlando Health, headquartered in Orlando, Florida, is a not-for-profit healthcare organization with $9.6 billion of assets under management that serves the southeastern United States and Puerto Rico.

Founded more than 100 years ago, the healthcare system is recognized around the world for Central Florida’s only pediatric and adult Level I Trauma program as well as the only state-accredited Level II Adult Trauma Center in Pinellas County. It is the home of one of the nation’s largest neonatal intensive care units, one of the only systems in the southeast to offer open fetal surgery to repair the most severe forms of spina bifida, the site of an Olympic athlete training facility and operator of one of the largest and highest performing clinically integrated networks in the region. Orlando Health has pioneered life-changing medical research and its Graduate Medical Education program hosts more than 350 residents and fellows.

The 3,487-bed system includes 33 hospitals and emergency departments – 26 of which are currently operational with seven coming soon. The system also includes nine specialty institutes, skilled nursing facilities, an in-patient behavioral health facility under the management of Acadia Healthcare, and more than 375 outpatient facilities that include physician clinics, imaging and laboratory services, wound care centers, home healthcare services in partnership with LHC Group, and urgent care centers in partnership with CareSpot Urgent Care. More than 4,950 physicians, representing more than 100 medical specialties and subspecialties have privileges across the Orlando Health system, which employs more than 29,000 team members and more than 1,400 physicians.

In FY 23, Orlando Health cared for 197,000 inpatients and 6.6 million outpatients.  The healthcare system provided nearly $1.3 billion in total impact to the communities it serves in the form of community benefit programs and services, Medicare shortfalls, bad debt, community-building activities and capital investments in FY 22, the most recent period for which this information is available.

Additional information can be found at http://www.orlandohealth.com, or follow us on LinkedIn, Facebook, Instagram and Twitter @orlandohealth.